Eclinso, a provider of clinical information technology, consulting and business process outsourcing services, has entered into a strategic partnership agreement with XClinical, an eClinical technology solutions company offering its CDISC-certified electronic data capture (EDC) and data management (DM) system MARVIN and related tools, such as STUDY COMPOSER and TABULATOR.
The combined solutions—Eclinso’s Trialforce Platform and XClinical's EDC system MARVIN—offer flexibility and adaptability to sponsors and CROs for capturing and managing their clinical data. Trialforce, a managed application platform, is fully compliant to industry standards 21CFR11, CDISC, HIPAA, W3C and GCP, with support for over 50 languages (including double byte languages such as Chinese). Trialforce is a cloud-based platform with no local software or hardware to support. Based on a Software as a Service (SaaS) pricing model, there are minimal upfront costs, lowering the initial licensing fees traditionally associated with EDC and data management solutions.
MARVIN can be used across all types of therapeutic areas; adapting to any type of clinical trial including phase I-IV interventional studies, medical device trials, observational studies, registry trials, prevention studies, genetic investigations, diagnostic trials and outcomes research. MARVIN is built on CDISC standards that enable pharmaceutical companies, CROs and MedTech companies to increase clinical trial efficiency. STUDY COMPOSER, the EDC design tool, offers an intuitive graphical point-and-click interface for defining a trial and creating relevant metadata. Study Composer automatically generates the eCRF design, accelerating the clinical trial process.
Combined with Trialforce, MARVIN offers visibility, exception management and analysis of information from clinical trials, enabling trial sponsors and managers to make critical decisions during and throughout a trial. Integration and interoperability through other Trialforce solutions, such as IVR and ePRO, can be provided easily and seamlessly.
"XClinical shares our philosophy of providing innovative solutions based on industry standards, which enables interoperability within our Trialforce platform,” said Frank Pijpers, CEO of Eclinso. “The convergence of cloud-based solutions such as Trialforce with MARVIN will significantly improve clinical trial efficiency while reducing costs."
Eclinso has offices in Switzerland,California and New Jersey. XClinical has operations in Germany, France and Massachusetts.